Rating Change
Needham analysts initiated coverage on Pulse Biosciences, Inc. (NASDAQ:PLSE) with a rating of Buy on August 17, 2026.
new coverageNASDAQ:PLSE
Needham Initiates Coverage on Pulse Biosciences, Inc. (PLSE) with Buy
Needham analysts initiated coverage on Pulse Biosciences, Inc. (NASDAQ:PLSE) with a rating of Buy on August 17, 2026.
At publication ·
What changed
Pulse Biosciences, Inc. (NASDAQ:PLSE) · new coverage
- Firm
- Needham
- Rating
- Buy
- Price at event
- $46.79
- Market capitalization
- $933.2M
At a glance
Key takeaways
- Needham initiated Buy coverage on Pulse Biosciences (PLSE) on August 17, 2026, with the stock trading at $46.79 and a market capitalization of $933.2 million.
Market Context
Pulse Biosciences, Inc. operates in the Healthcare sector. The stock currently trades at $46.79 with a market capitalization of $933.2M. The stock has gained 184.1% over the past 52 weeks.
Analyst coverage from Needham provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Pulse Biosciences, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Pulse Biosciences, Inc.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 17, 2026 | Needham | Buy | N/A |
| Aug 10, 2026 | Canaccord Genuity | Buy | N/A |
| Jun 04, 2026 | Canaccord Genuity | Buy | N/A |
| Jul 07, 2025 | Oppenheimer | Outperform | N/A |
| Sep 21, 2022 | Maxim Group | Hold | N/A |
Related Tools: Analyst Ratings Dashboard | View PLSE Stock Page
Frequently Asked Questions
What does the Buy rating mean for PLSE?
A rating of Buy from Needham reflects the analyst's outlook on Pulse Biosciences, Inc. (NASDAQ:PLSE). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the PLSE forecast page.